z-logo
open-access-imgOpen Access
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial
Author(s) -
Tázio Vanni,
Beatriz Thomé,
Erin Sparrow,
Martin Friede,
Christopher B. Fox,
Anna Marie Beckmann,
Chuong Huynh,
Gabriella Mondini,
Daniela Haydee Ramos Silveira,
Juliana Yukari Kodaira Viscondi,
Patrícia Emilia Braga,
A. R. Da Silva,
Maria da Graça Salomão,
Roberta O. Piorelli,
Joane Prado Santos,
Vera Lúcia Gattás,
Maria Beatriz Bastos Lucchesi,
Mayra Martho Moura de Oliveira,
Marcelo Eiji Koike,
Esper G. Kallás,
Lúcia Maria Arruda Campos,
Eduardo Barbosa Coelho,
Marilda Mendonça Siqueira,
Cristiana C. Garcia,
Milene Dias Miranda,
Terezinha Maria de Paiva,
María do Carmo Sampaio Tavares Timenetsky,
Eduardo Alfredo Adami,
Milena Apetito Akamatsu,
Paulo Lee Ho,
Alexander Roberto Precioso
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0274943
Subject(s) - medicine , adjuvant , adverse effect , placebo , immunogenicity , titer , reactogenicity , influenza vaccine , randomized controlled trial , antibody titer , vaccination , immunology , gastroenterology , virology , antibody , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom